TrialJournal of diabetes research2018

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial.

Glaucia S Tres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.